跳至主要内容
临床试验/IRCT2016010825903N1
IRCT2016010825903N1已完成3 期

Role of hemoglobin and the effect of it’s correction on pregnancy outcome in minor and intermedia thalasemia patients

Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 35 years(—)
性别
Female

入选标准

  • Inclusion Criteria: thalassemia minor and intermedia women and pregnant
  • With hemoglobin over 8.5; Bearing a singleton baby; Patient with ages: 20-35 years old.

排除标准

  • Patients with metabolic diseases such as cushing syndrome, Hypothyroidism and hyperthyroidism; chronic diseases such as rheumatic disease, autoimmune and antiphospholipid syndrome.

研究者

发起方
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences

相似试验